RSNA 2016

Abstract Archives of the RSNA, 2016


RCA31

Prostate MRI (Hands-on)

Tuesday, Nov. 29 8:00AM - 10:00AM Room: S401AB

GUMR

AMA PRA Category 1 Credits ™: 1.50
ARRT Category A+ Credit: 0

Jelle O. Barentsz, MD, PhD, Nijmegen, Netherlands (Presenter) Research Consultant, SPL Medical
Jurgen J. Futterer, MD, PhD, Nijmegen, Netherlands, (jurgen.futterer@radboudumc.nl ) (Presenter) Research Grant, Medtronic, Inc; Research Grant, Siemens AG
Roel D. Mus, MD, Nijmegen, Netherlands (Presenter) Nothing to Disclose
Geert M. Villeirs, MD, PhD, Ghent, Belgium (Presenter) Nothing to Disclose
Baris Turkbey, MD, Bethesda, MD (Presenter) Nothing to Disclose
Jeffrey C. Weinreb, MD, New Haven, CT (Presenter) Nothing to Disclose
Antonio C. Westphalen, MD, Mill Valley, CA, (antonio.westphalen@ucsf.edu) (Presenter) Scientific Advisory Board, 3DBiopsy LLC ; Research Grant, Verily Life Sciences LLC
Rianne R. Engels, Cuijk, Netherlands (Presenter) Nothing to Disclose
Joyce G. Bomers, Nijmegen, Netherlands (Presenter) Nothing to Disclose
Renske L. Van Delft, Nijmegen, Netherlands (Presenter) Nothing to Disclose
Laura I. Stoilescu, Nijmegen, Netherlands (Presenter) Nothing to Disclose
Daniel J. Margolis, MD, Los Angeles, CA (Presenter) Nothing to Disclose
Patrik Zamecnik, MD, Heidelberg, Germany (Presenter) Officer, SPL Medical BV
Sadhna Verma, MD, Cincinnati, OH (Presenter) Nothing to Disclose
LEARNING OBJECTIVES

1) Understand the Pi-RADS v2 Category assessment to detect and localize signifant cancer for both peripheral zone and transitional zone lesions. 2) Recognize benign pathology like inflammation and BPH and to differentiate these from significant prostate cancers.

ABSTRACT

In this Hands-On Workshop, the participants will be able to review up to 40 multi-parametric MRI cases with various prostatic pathology using a dedicated workstation. Focus will be on the overall assessment of PI-RADS v2 category, which enables them to score the probability of the presence of a significant cancer in patients with elevated PSA and/or clinical suspicion. All cases are from daily non-academic practice, and have various levels of difficulty. The cases include: easy and difficult significant peripheral- transition- and central zone cancers, inflammation, BPH, and the most common pitfalls. Internationally renowned teachers will guide the participants during their PI-RADS v2 scoring. There will be 50 workstations available. Participants will be able to use their own laptops through a secure WiFi connection.

Active Handout:Renske Lian Van Delft

http://abstract.rsna.org/uploads/2016/16002001/RCA Coursebook Prostate hands on course.pdf